Ruxolitinib cream demonstrated favorable safety and efficacy in pediatric atopic dermatitis, highlighting JAK inhibitors' ...
Our top content coverage from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlighted ...
For those and other reasons, targeted oral therapies like Bruton tyrosine kinase inhibitors (BTKis) and the BCL-2 inhibitor ...
Jonathan Strober, MD, discusses advancements in pediatric myasthenia gravis, emphasizing the need for better treatment standards and effective patient care strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback